3,916
Views
12
CrossRef citations to date
0
Altmetric
Research Article

A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension

, , &
Pages 1898-1909 | Received 24 Jul 2018, Accepted 10 Sep 2018, Published online: 15 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wenhai Fu, Wenjun He, Yuexin Li, Yangxiao Chen, Jingyi Liang, Hui Lei, Lin Fu, Yanghang Chen, Ni Ren, Qian Jiang, Yi Shen, Ran Ma, Tao Wang, Xinni Wang, Nuofu Zhang, Dakai Xiao & Chunli Liu. (2021) Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis. Drug Delivery 28:1, pages 1007-1019.
Read now

Articles from other publishers (11)

Junichi Omura, Yogeshwar Makanji, Nobuhiro Tanabe, Dae Young Yu, Jin Yu Tan, Sooyeol Lim, Mahsa H. Kouhkamari, Jeremy Casorso, David Bin-Chia Wu & Paul Bloomfield. (2023) Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study. Pulmonary Therapy.
Crossref
Mahna Ekhlasi, Shiva Sheikhi, Zahra Karimi Majd, Farzad Peiravian & Nazila Yousefi. (2023) Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran. Value in Health Regional Issues 34, pages 78-85.
Crossref
Cheng-Yu Tsai, Chuan-Wei Shen, Hsuan-Lin Lai & Chung-Yu Chen. (2023) Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study. Frontiers in Pharmacology 13.
Crossref
Ioannis T. Farmakis, Eftychia Demerouti, Panagiotis Karyofyllis, George Karatasakis, Maria Stratinaki, Dimitrios Tsiapras, George Athanassopoulos, Vassilios Voudris & George Giannakoulas. (2021) Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?. Journal of Clinical Medicine 10:13, pages 2826.
Crossref
Chao Liu, Junmin Chen, Yanqiu Gao, Bao Deng & Kunshen Liu. (2021) Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Weisi Lai, Yiling Ding & Lieming Wen. (2021) Long‐term outcomes of pregnant women with pulmonary hypertension diagnosed by echocardiography: a retrospective cohort study in a single center from China. Pulmonary Circulation 11:1, pages 1-8.
Crossref
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung & Andreas Karabis. (2020) Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal. BMC Pulmonary Medicine 20:1.
Crossref
Yu. G. Belotserkovskaya. (2020) Рossibilities of clinical application of modern nebulizers. Meditsinskiy sovet = Medical Council:17, pages 50-55.
Crossref
Maja Petrovič & Igor Locatelli. (2019) A Bayesian Network Meta-analysis of Add-on Drug Therapies Specific for Pulmonary Arterial Hypertension. Annals of Pharmacotherapy 54:5, pages 423-433.
Crossref
Lopamudra Kirtania, Rituparna Maiti, Anand Srinivasan & Archana Mishra. (2019) Effect of Combination Therapy of Endothelin Receptor Antagonist and Phosphodiesterase-5 Inhibitor on Clinical Outcome and Pulmonary Haemodynamics in Patients with Pulmonary Arterial Hypertension: A Meta-Analysis. Clinical Drug Investigation 39:11, pages 1031-1044.
Crossref
Noémi B. A. Roy & Christian Babbs. (2019) The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I. British Journal of Haematology 185:3, pages 436-449.
Crossref